Nitrogen

Description

NITROGEN, COMPRESSED NF UN1066 is a non-flammable gas with the Chemical Abstracts Service (CAS) number 7727-37-9.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may render it contraindicated in certain circumstances. There are no reported teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Administration of this medication is restricted to licensed practitioners who possess experience in the use and administration of Nitrogen. These practitioners must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration.

The recommended route of administration is via respiratory inhalation. It is imperative that the practitioner follows established protocols for inhalation to ensure optimal delivery and efficacy of the medication. The specific dosage and frequency should be determined based on individual patient needs and clinical judgment, adhering to the guidelines established for the use of Nitrogen.

Contraindications

There are no specific contraindications identified for this product. However, it is advised to avoid contact with eyes, skin, or clothing, as liquid exposure may lead to irritation. Additionally, the product should not be dropped or have its label removed to ensure proper usage and identification.

Warnings and Precautions

Administration of Nitrogen may pose significant hazards and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazards of Nitrogen Use WARNING: Nitrogen is an extremely cold liquid and gas under pressure, which can lead to rapid suffocation and severe frostbite.

General Precautions Caution is advised when handling Nitrogen due to its high-pressure gas nature, which can also result in rapid suffocation. It is essential to store and use Nitrogen in well-ventilated areas. Equipment must be rated for cylinder pressure, and a backflow preventive device should be utilized in the piping. Cylinder temperatures must not exceed 52°C (125°F). Practitioners should ensure that the valve is closed after each use and when the cylinder is empty. All handling should be conducted in accordance with the Material Safety Data Sheet (MSDS).

Direct contact with the liquid form of Nitrogen should be avoided; it must not come into contact with eyes, skin, or clothing. When withdrawing liquid, appropriate personal protective equipment, including a face shield and gloves, should be worn. Containers should not be dropped, and suitable hand trucks should be employed for movement.

Emergency Medical Assistance In the event of inhalation, the individual should be removed to fresh air immediately. If breathing has ceased, artificial respiration should be administered. If breathing is difficult, supplemental oxygen should be provided, and a physician should be contacted without delay. In cases of frostbite, immediate medical treatment is necessary.

No specific laboratory tests are recommended for monitoring the use of Nitrogen. However, practitioners should remain vigilant and prepared to respond to any adverse effects or emergencies that may arise during administration.

Side Effects

Patients may experience serious adverse reactions associated with exposure to extremely cold liquid and gas under pressure. These reactions include the potential for rapid suffocation and severe frostbite.

In the event of inhalation, it is critical to remove the patient to fresh air immediately. If the patient is not breathing, artificial respiration should be administered. Should breathing difficulties arise, supplemental oxygen must be provided, and a physician should be contacted without delay.

In cases of frostbite, it is imperative to obtain medical treatment immediately to address the injury effectively.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Administration of Nitrogen during pregnancy may pose potential risks to both the pregnant patient and the developing fetus. The use of Nitrogen is contraindicated or may be hazardous, and it is recommended that it be administered only by or under the supervision of a licensed practitioner who is experienced in its use. Given the potential for adverse effects, healthcare professionals should carefully consider the risks versus benefits when evaluating the use of Nitrogen in pregnant patients. It is essential to monitor for any potential fetal impacts and to provide appropriate counseling regarding the risks associated with its administration during pregnancy.

Lactation

There is no specific information regarding the use of Nitrogen in lactating mothers or lactation considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to nursing mothers, as the effects on breastfed infants are not established. It is advisable to monitor breastfed infants for any potential adverse effects if the mother is treated with this medication.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the drug insert for Nitrogen. Healthcare professionals should exercise caution and consider individual patient factors when prescribing this medication to patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the absence of data to guide treatment decisions.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, monitor for symptoms, and provide appropriate supportive care in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No specific postmarketing experience details have been reported. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated in certain situations. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must emphasize the caution associated with Nitrogen as it is a high-pressure gas that can lead to rapid suffocation. Patients should be informed about the importance of storing and using Nitrogen in areas with adequate ventilation. It is critical to utilize equipment that is rated for cylinder pressure and to incorporate a backflow preventive device in the piping system. Additionally, patients should be made aware that cylinder temperatures must not exceed 52°C (125°F) and that the valve should be closed after each use and when the cylinder is empty.

Patients should be instructed to follow the guidelines outlined in the Material Safety Data Sheet (MSDS) for safe handling. In the event of inhalation, patients should be removed to fresh air immediately. If the patient is not breathing, artificial respiration should be administered, and if breathing is difficult, oxygen should be provided. A physician should be contacted without delay.

Healthcare providers should also warn patients about the extremely cold nature of the liquid and gas under pressure, which can cause rapid suffocation and severe frostbite. Patients must be cautioned against allowing the liquid to come into contact with their eyes, skin, or clothing. When withdrawing liquid, it is imperative that patients wear a face shield and gloves to protect themselves. They should be advised not to drop the cylinder and to use a suitable hand truck for moving containers.

In the case of frostbite, patients should seek medical treatment immediately.

Storage and Handling

The product is supplied in cylinders that must be stored and used in areas with adequate ventilation. It is essential to ensure that cylinder temperatures do not exceed 52°C (125°F). After each use and when the cylinder is empty, the valve should be closed to maintain safety.

For handling, it is crucial to utilize equipment that is rated for the cylinder pressure and to incorporate a backflow preventive device in the piping system. When withdrawing liquid, personnel must wear a face shield and gloves to protect against potential hazards. Containers should always be maintained in an upright position, and connections should not be changed or forced to fit improperly.

To prevent accidents, it is important to avoid getting liquid in the eyes, on the skin, or on clothing. Containers should not be dropped; instead, a suitable hand truck should be used for movement. All handling and usage should be conducted in accordance with the Material Safety Data Sheet (MSDS) to ensure safety and compliance.

Additional Clinical Information

Administration of Nitrogen is indicated via respiratory inhalation and should only be performed by or under the supervision of a licensed practitioner experienced in its use. Clinicians must be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be counseled on the potential hazards of Nitrogen, including the risk of rapid suffocation due to high-pressure gas. It is crucial to store and use Nitrogen with adequate ventilation and to utilize equipment rated for cylinder pressure. Precautions include using a backflow preventive device in the piping and ensuring cylinder temperatures do not exceed 52°C (125°F). In the event of inhalation, patients should be moved to fresh air, and if breathing is difficult, oxygen should be administered. Immediate medical attention is required for frostbite, and appropriate protective gear should be worn during liquid withdrawal to prevent severe frostbite and injury.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by INDUSTRIAL WELDING SUPPLY CO. OF HARVEY, INC.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)